WASHINGTON (Reuters) - A GlaxoSmithKline Plc plant in Canada that makes the flu vaccine Flulaval has been cited by the U.S. Food and Drug Administration for failing to meet quality control standards. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/e60_nNHaPZI/story01.htm
Read More
No comments:
Post a Comment